April 13, 2026 |
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.

Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success – including market analysis, sales teams, MSLs, training, launch meeting support, congress experiences, and product value demonstration.
Our client is a US biotechnology company that specializes in developing therapies for complex and chronic conditions. For many years, the firm has been working on what’s become the first new FDA-approved therapy of its kind in almost two decades.
Our client’s landmark product is an easy-to-use therapy that allows for rapid absorption and targets various receptors. In clinical trials, the treatment was shown to significantly reduce pain.
Primarily, the client needed a commercialization partner to rapidly set up a large, flexible nationwide sales team ready for the product launch in October 2025.
Read the full case study here.
This content was provided by Inizio
Latest Content from Inizio
Conducting research in one of the world’s largest pharma markets
The process of demand calibration of preference share (down-weighting) is often a proprietary “black box” technique, which can mean that the client is unsure how the calibrated figure has been…
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Published in eye for pharma 30 January by Marc Yates
Published in eye for pharma 12 December by Marc Yates
Published in Eye for Pharma 10 November by Marc Yates
Pegasus, the UK’s leading independent health communications consultancy, picked up the “Specialist Consultancy of the Year” award at the PRCA Awards 2014.
Brighton-based Pegasus, the UK’s leading independent health communications consultancy, is pleased to be supporting Naomi’s Flight – a bold and unique theatrical performance tour that highlights the impact of dementia…
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in…
